These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 594800)
21. [Vaginal adenocarcinoma as a late result of treatment of threatened abortion with diethylstilbestrol]. Presl J Cesk Gynekol; 1973 Jul; 38(6):473-4. PubMed ID: 4731614 [No Abstract] [Full Text] [Related]
22. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Int Surg; 1977 Mar; 62(3):152-5. PubMed ID: 852937 [No Abstract] [Full Text] [Related]
23. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals. Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019 [TBL] [Abstract][Full Text] [Related]
24. Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Robboy SJ; Kaufman RH; Prat J; Welch WR; Gaffey T; Scully RE; Richart R; Fenoglio CM; Virata R; Tilley BC Obstet Gynecol; 1979 Mar; 53(3):309-17. PubMed ID: 424102 [No Abstract] [Full Text] [Related]
25. Vaginal adenocarcinoma in young women. Lancet; 1971 May; 1(7709):1111-2. PubMed ID: 4102630 [No Abstract] [Full Text] [Related]
26. DES update. Interview by Arthur I. Holleb. Herbst AL CA Cancer J Clin; 1980; 30(6):326-32. PubMed ID: 6780138 [No Abstract] [Full Text] [Related]
28. Editorial: Relationship of stilbestrol exposure in utero to vaginal lesions in adolescence. Carrington ER J Pediatr; 1974 Aug; 85(2):295-6. PubMed ID: 4841967 [No Abstract] [Full Text] [Related]
29. Proceedings: Vaginal and cervical meoplasia after exposure to stilboestrol in utero. Jordon JA Br J Obstet Gynaecol; 1975 Jul; 82(7):588. PubMed ID: 1148144 [No Abstract] [Full Text] [Related]
30. [Current guidelines for gynecological examination in DES daughters]. Helmerhorst TJ; Wijnen JA; Direcks AP Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2065-7. PubMed ID: 1407208 [No Abstract] [Full Text] [Related]
31. DES. Effects of in utero exposure. Birenboim N J Kans Med Soc; 1982 Dec; 83(12):634-8. PubMed ID: 7153637 [No Abstract] [Full Text] [Related]
32. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma. Edelman DA Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761 [TBL] [Abstract][Full Text] [Related]
33. [The stilbestrol--adenosis--carcinoma--syndrome. A review]. Ulfelder H Geburtshilfe Frauenheilkd; 1975 May; 35(5):329-33. PubMed ID: 1150064 [No Abstract] [Full Text] [Related]
35. From the National Cancer Institute--An update on the DES problem: important information about vaginal and cervical cancers. Med Times; 1977 Nov; 105(11):(114) 31d-34d passim. PubMed ID: 916851 [No Abstract] [Full Text] [Related]
36. The stilbestrol child. Franklin EW; Dudley AG; Caputo TA J Med Assoc Ga; 1974 Feb; 63(2):66-7. PubMed ID: 4130464 [TBL] [Abstract][Full Text] [Related]
37. DES-transplacental teratogen-and possibly also carcinogen. Ulfelder H Teratology; 1976 Feb; 13(1):101-3. PubMed ID: 1257911 [No Abstract] [Full Text] [Related]
38. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Adam E; Decker DG; Herbst AL; Noller KL; Tilley BC; Townsend DE Cancer Res; 1977 Apr; 37(4):1249-51. PubMed ID: 844051 [No Abstract] [Full Text] [Related]
39. Genital tract anomalies and cancer in females exposed in utero to diethylstilbestrol. Brief report on the DESAD project. Sestili MA Public Health Rep; 1977; 92(5):481-4. PubMed ID: 910027 [No Abstract] [Full Text] [Related]